Reports for MINT PHARMACEUTICALS INC

Company Name

MINT PHARMACEUTICALS INC

Totals

Shortage reports

132

Actual shortage: 30 (23%)
Anticipated shortage: 0 (0%)
Avoided shortage: 0 (0%)
Resolved: 102 (77%)

Discontinuation Reports

29

To be discontinued: 0 (0%)
Discontinued: 29 (100%)
Reversed: 0 (0%)

Late reports

33 (20%)

Overdue reports

15 (50%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
MINT-GLICLAZIDE MR 30MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-03-19 2024-03-19 222750
MINT-GLICLAZIDE MR 60MG TABLET (EXTENDED-RELEASE) Actual shortage 2020-03-09 2020-03-10 108289
MINT-HYDRALAZINE 10MG TABLET Resolved 2019-02-28 2019-09-03 77148
MINT-IRBESARTAN 75MG TABLET Resolved 2019-01-03 2021-07-12 71063
MINT-IRBESARTAN/HCTZ 12.5MG 300.0MG TABLET Resolved 2019-01-03 2019-01-16 71060
MINT-LACOSAMIDE 50MG TABLET Resolved 2021-01-11 2021-02-23 131336
MINT-LEVOCARB 10MG 100MG TABLET Actual shortage 2017-12-08 2017-12-09 32263
MINT-LEVOCARB 25MG 100MG TABLET Actual shortage 2017-12-08 2017-12-09 32270
MINT-LEVOCARB 25MG 250MG TABLET Actual shortage 2017-12-08 2017-12-09 32274
MINT-LOSARTAN 100.0MG TABLET Resolved 2019-01-03 2019-06-19 71066
MINT-LOSARTAN/HCTZ 12.5MG 50MG TABLET Resolved 2019-02-04 2020-01-27 74450
MINT-LOSARTAN/HCTZ 50MG 12.5MG TABLET Resolved 2020-04-25 2020-07-13 113193
MINT-LOSARTAN/HCTZ DS 25.0MG 100.0MG TABLET Resolved 2019-04-08 2020-07-13 80811
MINT-METFORMIN 500MG TABLET Actual shortage 2019-02-04 2019-02-05 74455
MINT-OLANZAPINE ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2018-01-09 2018-07-25 35467
MINT-OLANZAPINE ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2020-03-09 2021-01-16 108295
MINT-OLANZAPINE ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2018-01-09 2018-07-25 35470
MINT-OLANZAPINE ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2020-03-09 2021-01-16 108298
MINT-OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Resolved 2018-01-09 2018-07-25 35473
MINT-OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Resolved 2020-03-09 2021-01-16 108301

Showing 21 to 40 of 132

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
MINT-IRBESARTAN/HCTZ 12.5MG 300MG TABLET Discontinued 2021-08-11 2021-08-11 143952
MINT-IRBESARTAN/HCTZ 12.5MG 150MG TABLET Discontinued 2021-08-11 2021-08-11 143956
MINT-IRBESARTAN/HCTZ 25MG 300MG TABLET Discontinued 2021-08-11 2021-08-11 143959
MINT-CITALOPRAM 20MG TABLET Discontinued 2023-05-02 2023-05-03 191439
MINT-CITALOPRAM 40MG TABLET Discontinued 2023-05-02 2023-05-03 191442
MINT-CLOPIDOGREL 75MG TABLET Discontinued 2018-08-16 2018-08-17 58283
MINT-CLOPIDOGREL 75MG TABLET Discontinued 2018-08-16 2018-08-17 58286
MINT-CLOPIDOGREL Discontinued 2019-02-04 2019-02-05 74435
MINT-CLOPIDOGREL Discontinued 2019-02-04 2019-02-05 74442
MINT-METFORMIN 850MG TABLET Discontinued 2020-03-09 2020-03-10 108292
MINT-ROSUVASTATIN 5MG TABLET Discontinued 2019-10-09 2019-10-10 95897
MINT-ROSUVASTATIN 10MG TABLET Discontinued 2019-10-09 2019-10-10 95900
MINT-ROSUVASTATIN 20MG TABLET Discontinued 2019-10-09 2019-10-10 95903
MINT-ROSUVASTATIN 40MG TABLET Discontinued 2019-10-09 2019-10-10 95907
MINT-SOLIFENACIN 5MG TABLET Discontinued 2019-10-09 2019-10-10 95913
MINT-SOLIFENACIN 10MG TABLET Discontinued 2019-10-09 2019-10-10 95916
MINT-DORZOLAMIDE/TIMOLOL 5MG 20MG SOLUTION Discontinued 2019-06-04 2019-06-04 85525
MINT-FENOFIBRATE E 145MG TABLET Discontinued 2020-04-25 2020-04-25 113175
MINT-LEVOFLOXACIN 250MG TABLET Discontinued 2022-10-02 2022-10-03 170853
MINT-LEVOFLOXACIN 500MG TABLET Discontinued 2022-10-02 2022-10-03 170856

Showing 1 to 20 of 29